{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:15:38Z","timestamp":1793924138987,"version":"4.8.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,12,19]],"date-time":"2007-12-19T00:00:00Z","timestamp":1198022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s00125-007-0890-y","type":"journal-article","created":{"date-parts":[[2007,12,18]],"date-time":"2007-12-18T12:23:41Z","timestamp":1197980621000},"page":"476-487","source":"Crossref","is-referenced-by-count":165,"title":["Presence of functional cannabinoid receptors in human endocrine pancreas"],"prefix":"10.1007","volume":"51","author":[{"given":"F. J.","family":"Berm\u00fadez-Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Baixeras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Cobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. L.","family":"Cuesta-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Juan-Pico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Milman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mechoulam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Nadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Rodr\u00edguez de Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,12,19]]},"reference":[{"key":"890_CR1","first-page":"605","volume":"34","author":"WA Devane","year":"1998","unstructured":"Devane WA, Dysarz FA 3rd, Johnson M, Melvin LS, Howlett AC (1998) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605\u2013613","journal-title":"Mol Pharmacol"},{"key":"890_CR2","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"WA Devane","year":"1992","unstructured":"Devane WA, Hanus L, Breuer A et al (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946\u20131949","journal-title":"Science"},{"key":"890_CR3","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","volume":"388","author":"N Stella","year":"1992","unstructured":"Stella N, Schweitzer P, Piomelli D (1992) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388:773\u2013778","journal-title":"Nature"},{"key":"890_CR4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","volume":"50","author":"R Mechoulam","year":"1995","unstructured":"Mechoulam R, Ben-Shabat S, Hanus L et al (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83\u201390","journal-title":"Biochem Pharmacol"},{"key":"890_CR5","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","volume":"4","author":"D Piomelli","year":"2003","unstructured":"Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4:873\u2013884","journal-title":"Nat Rev Neurosci"},{"key":"890_CR6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nn1457","volume":"8","author":"V Marzo Di","year":"2005","unstructured":"Di Marzo V, Matias I (2005) Endocannabinoid control of food intake and energy balance. Nat Neurosci 8:585\u2013589","journal-title":"Nat Neurosci"},{"key":"890_CR7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1172\/JCI17725","volume":"112","author":"D Cota","year":"2003","unstructured":"Cota D, Marsicano G, Tschop M et al (2003) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112:423\u2013431","journal-title":"J Clin Invest"},{"key":"890_CR8","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1523\/JNEUROSCI.22-21-09612.2002","volume":"22","author":"R Gomez","year":"2002","unstructured":"Gomez R, Navarro M, Ferrer B et al (2002) A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci 22:9612\u20139617","journal-title":"J Neurosci"},{"key":"890_CR9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","volume":"136","author":"TC Kirkham","year":"2002","unstructured":"Kirkham TC, Williams CM, Fezza F, Di Marzo V (2002) Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136:550\u2013557","journal-title":"Br J Pharmacol"},{"key":"890_CR10","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35071088","volume":"410","author":"V Marzo Di","year":"2001","unstructured":"Di Marzo V, Goparaju SK, Wang L et al (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410:822\u2013825","journal-title":"Nature"},{"key":"890_CR11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.neuropharm.2006.03.029","volume":"51","author":"FJ Pavon","year":"2006","unstructured":"Pavon FJ, Bilbao A, Hernandez-Folgado L et al (2006) Antiobesity effects of the novel in vivo neutral cannabinoid receptor Antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole\u2013LH 21. Neuropharmacology 51:358\u2013366","journal-title":"Neuropharmacology"},{"key":"890_CR12","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","volume":"115","author":"D Osei-Hyiaman","year":"2005","unstructured":"Osei-Hyiaman D, DePetrillo M, Pacher P et al (2005) Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 115:1298\u20131305","journal-title":"J Clin Invest"},{"key":"890_CR13","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.2337\/diabetes.54.10.2838","volume":"54","author":"S Engeli","year":"2005","unstructured":"Engeli S, Bohnke J, Feldpausch M et al (2005) Activation of the peripheral endocannabinoid system in human obesity. Diabetes 54:2838\u20132843","journal-title":"Diabetes"},{"key":"890_CR14","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","volume":"365","author":"LF Gaal Van","year":"2005","unstructured":"Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, Rossner S, RIO-Europe Study Group (2005) Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365:1389\u20131397","journal-title":"Lancet"},{"key":"890_CR15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","volume":"295","author":"FX Pi-Sunyer","year":"2006","unstructured":"Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J, RIO-North America Study Group (2006) Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 295:761\u2013775","journal-title":"JAMA"},{"key":"890_CR16","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/S0140-6736(06)69571-8","volume":"368","author":"AJ Scheen","year":"2006","unstructured":"Scheen AJ, Finer N, Hollander P, Jensen MD, Van Gaal LF, RIO-Diabetes Study Group (2006) Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet 368:1660\u20131672","journal-title":"Lancet"},{"key":"890_CR17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ceca.2005.10.005","volume":"39","author":"P Juan-Pico","year":"2006","unstructured":"Juan-Pico P, Fuentes E, Berm\u00fadez-Silva FJ et al (2006) Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic \u03b2-cells. Cell Calcium 39:155\u2013162","journal-title":"Cell Calcium"},{"key":"890_CR18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejphar.2005.12.016","volume":"531","author":"FJ Bermudez-Silva","year":"2006","unstructured":"Bermudez-Silva FJ, Serrano A, Diaz-Molina FJ et al (2006) Activation of cannabinoid CB1 receptors induces glucose intolerance in rats. Eur J Pharmacol 531:282\u2013284","journal-title":"Eur J Pharmacol"},{"key":"890_CR19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejphar.2007.02.066","volume":"565","author":"FJ Bermudez-Silva","year":"2007","unstructured":"Bermudez-Silva FJ, Suarez J, Sanchez Vera I et al (2007) Role of cannabinoid CB2 receptors in glucose homeostasis in rats. Eur J Pharmacol 565:207\u2013211","journal-title":"Eur J Pharmacol"},{"key":"890_CR20","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1210\/jc.2005-2679","volume":"91","author":"I Matias","year":"2006","unstructured":"Matias I, Gonthier MP, Orlando P et al (2006) Regulation, function and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J Clin Endocrin Metab 91:3171\u20133180","journal-title":"J Clin Endocrin Metab"},{"key":"890_CR21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2337\/diab.37.4.413","volume":"37","author":"C Ricordi","year":"1988","unstructured":"Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW (1988) Automated method for isolation of human pancreatic islets. Diabetes 37:413\u2013420","journal-title":"Diabetes"},{"key":"890_CR22","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1016\/j.transproceed.2005.09.074","volume":"37","author":"AL Cuesta-Munoz","year":"2005","unstructured":"Cuesta-Munoz AL, Briones RM, Mellado-Gil JM et al (2005) Internal assessment of a novel islet isolation facility in Spain. Transplant Proc 37:3404\u20133406","journal-title":"Transplant Proc"},{"key":"890_CR23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.npp.1301034","volume":"32","author":"AC Hansson","year":"2007","unstructured":"Hansson AC, Bermudez-Silva FJ, Malinen H et al (2007) Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference. Neuropsychopharmacology 32:117\u2013126","journal-title":"Neuropsychopharmacology"},{"key":"890_CR24","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0022-3565(24)38289-8","volume":"289","author":"CJ Hillard","year":"1999","unstructured":"Hillard CJ, Manna S, Greenberg MJ et al (1999) Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J Pharmacol Exp The 289:1427\u20131433","journal-title":"J Pharmacol Exp The"},{"key":"890_CR25","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1016\/S0968-0896(99)00219-9","volume":"7","author":"JW Huffman","year":"1999","unstructured":"Huffman JW, Liddle J, Yu S et al (1999) 3-(1\u2032,1\u2032-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor. Bioorg Med Chem 7:2905\u20132914","journal-title":"Bioorg Med Chem"},{"key":"890_CR26","doi-asserted-by":"crossref","first-page":"PL191","DOI":"10.1016\/S0024-3205(97)00690-5","volume":"61","author":"SJ Gatley","year":"1997","unstructured":"Gatley SJ, Lan R, Pyatt B, Gifford AN, Volkow ND, Makriyannis A (1997) Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors. Life Sci 61:PL191\u2013PL197","journal-title":"Life Sci"},{"key":"890_CR27","first-page":"391","volume":"51","author":"DAD Pettit","year":"1998","unstructured":"Pettit DAD, Harrison MP, Olson JM et al (1998) Immunohistochemical localization of the neural cannabinoid receptor in rat brain. J Neurosci Methods 51:391\u2013402","journal-title":"J Neurosci Methods"},{"key":"890_CR28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1","volume":"422","author":"M Egertov\u00e1","year":"2000","unstructured":"Egertov\u00e1 M, Elphick MR (2000) Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB1. J Comp Neurol 422:159\u2013171","journal-title":"J Comp Neurol"},{"key":"890_CR29","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.brainres.2004.06.065","volume":"1021","author":"JC Ashton","year":"2004","unstructured":"Ashton JC, Zheng Y, Liu P et al (2004) Immunohistochemical characterisation and localisation of cannabinoid CB1 receptor protein in the rat vestibular nucleus complex and the effects of unilateral vestibular deafferentation. Brain Res 1021:264\u2013271","journal-title":"Brain Res"},{"key":"890_CR30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00418-005-0127-4","volume":"126","author":"R Roche","year":"2006","unstructured":"Roche R, Hoareau L, Bes-Houtmann S et al (2006) Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes. Histochem Cell Biol 126:177\u2013187","journal-title":"Histochem Cell Biol"},{"key":"890_CR31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.1115740","volume":"310","author":"MD Sickle Van","year":"2005","unstructured":"Van Sickle MD, Duncan M, Kingsley PJ et al (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310:329\u2013332","journal-title":"Science"},{"key":"890_CR32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","volume":"1071","author":"JP Gong","year":"2006","unstructured":"Gong JP, Onaivi ES, Ishiguro H et al (2006) Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain. Brain Res 1071:10\u201323","journal-title":"Brain Res"},{"key":"890_CR33","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","volume":"99","author":"TP Dinh","year":"2002","unstructured":"Dinh TP, Carpenter D, Leslie FM et al (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A 99:10819\u201310824","journal-title":"Proc Natl Acad Sci U S A"},{"key":"890_CR34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","volume":"384","author":"BF Cravatt","year":"1996","unstructured":"Cravatt BF, Giang DK, Mayfield SP et al (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384:83\u201387","journal-title":"Nature"},{"key":"890_CR35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0014-2999(00)00786-X","volume":"408","author":"A Giuffrida","year":"2000","unstructured":"Giuffrida A, Rodriguez de Fonseca F, Nava F, Loubet-Lescoulie P, Piomelli D (2000) Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404. Eur J Pharmacol 408:161\u2013168","journal-title":"Eur J Pharmacol"},{"key":"890_CR36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1210\/er.2005-0009","volume":"27","author":"U Pagotto","year":"2005","unstructured":"Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R (2005) The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 27:73\u2013100","journal-title":"Endocr Rev"},{"key":"890_CR37","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/376590a0","volume":"376","author":"L Venance","year":"1995","unstructured":"Venance L, Piomelli D, Glowinski J, Giaume C (1995) Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. Nature 376:590\u2013594","journal-title":"Nature"},{"key":"890_CR38","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.2337\/diabetes.54.6.1798","volume":"54","author":"MA Ravier","year":"2005","unstructured":"Ravier MA, Guldenagel M, Charollais A et al (2005) Loss of connexin36 channels alters beta-cell coupling, islet synchronization of glucose-induced Ca2+ and insulin oscillations, and basal insulin release. Diabetes 54:1798\u20131807","journal-title":"Diabetes"},{"key":"890_CR39","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1210\/jc.2006-1578","volume":"92","author":"V Singh","year":"2007","unstructured":"Singh V, Brendel MD, Zacharias S et al (2007) Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets. J Clin Endocrinol Metab 92:673\u2013680","journal-title":"J Clin Endocrinol Metab"},{"key":"890_CR40","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.2337\/diabetes.54.12.3510","volume":"54","author":"A Tabarin","year":"2005","unstructured":"Tabarin A, Diz-Chaves Y, Carmona M del C et al (2005) Resistance to diet-induced obesity in mu-opioid receptor-deficient mice: evidence for a \u201cthrifty gene\u201d. Diabetes 54:3510\u20133516","journal-title":"Diabetes"},{"key":"890_CR41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brainresrev.2005.10.004","volume":"51","author":"D Cota","year":"2006","unstructured":"Cota D, Tschop MH, Horvath TL, Levine AS (2006) Cannabinoids, opioids and eating behavior: the molecular face of hedonism? Brain Res Rev 51:85\u2013107","journal-title":"Brain Res Rev"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-007-0890-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-007-0890-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-007-0890-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T22:51:45Z","timestamp":1737672705000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-007-0890-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,19]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["890"],"URL":"https:\/\/doi.org\/10.1007\/s00125-007-0890-y","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,19]]}}}